Log In
BCIQ
Print this Print this
 

Q-Exenatide

  Manage Alerts
Collapse Summary General Information
Company Midatech Pharma plc
DescriptionSustained release formulation of Exenatide using Midatech's polymer microspheres
Molecular Target Glucagon-like peptide-1 (GLP-1)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today